IQVIA executive testifies before Congress on early clinical trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to IQVIA executive testifies before Congress on early clinical trials
(NYSE: IQV) Delayed: 269.44 +0.62 (0.23%)
Previous Close $268.82    52 Week High $ 
Open $273.15    52 Week Low $ 
Day High $273.88    P/E N/A 
Day Low $267.92    EPS $ 
Volume 1,714,584